LONG BEACH, Calif.--(BUSINESS WIRE)--#Laserfiche--New research by Medical Group Management Association (MGMA) and Laserfiche — the leading SaaS provider of intelligent...
LAS VEGAS, NV / ACCESSWIRE / November 28, 2023 / Canopus Biopharma Inc. (OTC PINK:CBIA) DBA Blue Heaven Coffee Inc....
BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing novel precision therapeutics for central nervous system...
BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
Maverick Medical AI is the first autonomous coding platform to surpass an 85 percent direct-to-bill rate by utilizing generative AI.WILMINGTON,...
Evinova will operate as a separate health-tech business within AstraZeneca Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human...
Southlake, TX, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the...
Healthcare technology veteran leads team connecting medical community to growing suite of physician-focused products and servicesNASHVILLE, Tenn.--(BUSINESS WIRE)--Montecito Medical has...
TORONTO, ON / ACCESSWIRE / November 14, 2023 / All About Seniors home care agency announced today that they have...
iCardio.ai's AI suite (pending FDA 510(k) clearance) includes instant automated interpretation of dozens of measurements of the heart, valvular disease...
Generative AI advances claim efficiency and accuracyFORT WORTH, Texas, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Advancements in artificial intelligence (AI)...
Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and...
Company to host investor call and webcast today, November 14th, at 8:30am EDTPITTSBURGH, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Predictive...
Strongly positive findings demonstrate the life-saving potential of the Jewel® Patch Wearable Cardioverter Defibrillator for patients at elevated risk of...
Study to assess efficacy and safety of CVN424 as a monotherapy in early-stage Parkinson’s disease BOSTON, Nov. 13, 2023 (GLOBE...
Data release to follow late-breaker poster presentation at AASLD The Liver Meeting® 2023EDISON, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) --...
Collaboration to utilize cutting-edge AI analysis platform for clinical trials and cancer screening test processingBERKELEY, Calif. and MAINZ, Germany, Nov....
PISCATAWAY, NJ / ACCESSWIRE / November 9, 2023 / Sensors in smartphones and smart speakers could help determine a person's...
MONTREAL, QC / ACCESSWIRE / November 8, 2023 / AlayaCare was honoured as an Enterprise-Industry leaders award winner as part...
PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics,...